About the Authors
- Graham M. West
-
Affiliations Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America, Mass Spectrometry and Proteomics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America
- Francis S. Willard
-
Affiliation Quantitative Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Kyle W. Sloop
-
Affiliation Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Aaron D. Showalter
-
Affiliation Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- Bruce D. Pascal
-
Affiliations Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America, Informatics Core, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America
- Patrick R. Griffin
-
* E-mail: pgriffin@scripps.edu
Affiliation Department of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, Florida, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts: FSW, KWS, and ADS are paid employees of Eli Lilly and Company and may own company stock or possess stock options. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GMW FSW KWS PRG. Performed the experiments: GMW ADS BP. Analyzed the data: GMW FSW KWS BP PRG. Contributed reagents/materials/analysis tools: ADS BP. Contributed to the writing of the manuscript: GMW FSW KWS PRG.